Education
About Us
Working with TipRanks
Follow Us
Emmaus Life Sciences Inc (EMMA)
OTHER OTC:EMMA
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.65M | $ 29.60M | $ 18.39M | $ 20.61M | $ 23.17M |
| Gross Profit | $ 15.45M | $ 28.25M | $ 15.80M | $ 17.30M | $ 20.92M |
| Operating Income | $ -1.89M | $ 3.54M | $ -6.59M | $ -6.13M | $ -43.00K |
| EBITDA | $ -1.89M | $ 3.57M | $ -5.50M | $ -12.76M | $ 28.00K |
| Net Income | $ -6.45M | $ -3.73M | $ -10.69M | $ -15.95M | $ 1.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.39M | $ 2.55M | $ 2.02M | $ 2.28M | $ 2.49M |
| Total Assets | $ 23.60M | $ 35.18M | $ 48.23M | $ 56.73M | $ 59.27M |
| Total Debt | $ 33.13M | $ 32.65M | $ 25.10M | $ 29.91M | $ 18.99M |
| Net Debt | $ 31.74M | $ 30.10M | $ 23.08M | $ 27.64M | $ 16.50M |
| Total Liabilities | $ 80.08M | $ 82.94M | $ 82.32M | $ 78.18M | $ 64.69M |
| Stockholders' Equity | $ -56.48M | $ -47.76M | $ -34.09M | $ -21.45M | $ -5.42M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.30M | $ -1.52M | $ -5.10M | $ -1.33M | $ -28.63M |
| Operating Cash Flow | $ -2.29M | $ -1.50M | $ -5.07M | $ -1.25M | $ -2.45M |
| Investing Cash Flow | $ 2.50M | $ -432.00K | $ -2.39M | $ -6.38M | $ 5.47M |
| Financing Cash Flow | $ -1.35M | $ 2.48M | $ 7.23M | $ 7.41M | $ -2.31M |